Using our optimal soft threshold for each cancer, the empirical p-values testing for differences in coexpression at KIR3DL2 were 0.02 for OV, 0.03 for BRCA, 0.002 for LUAD, and 0.05 for SKCM. This evidence concerns the gene KIR3DL2 and cancer.